NPK International Inc. NPKI 深 沪
已收盘 02-06 16:00:00 美东时间
14.11
+0.420
+3.07%
华盛通- 最 高14.245
- 今 开13.84
- 成交量 96.75万股
- 最 低 13.8001
- 昨 收 13.69
- 总市值 11.92亿
- 52周最高 14.685
- 市盈率 静 27.12
- 换手率 1.15%
- 52周最低 4.76
- 委 比 65.40%
- 总股本 8449.47万
- 历史最高 14.685
- 量 比 1.46
- 振 幅 3.25%
- 历史最低 0.65
- 每 手 1
- 风险率 2.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
HC Wainwright & Co. Maintains Buy on NPK International, Raises Price Target to $18
HC Wainwright & Co. analyst Amit Dayal maintains NPK International (NYSE:NPKI) with a Buy and raises the price target from $12 to $18.
2025-11-03 19:08
Donald Young Resigns from NPK International Board
NPK International ( ($NPKI) ) has issued an announcement. Donald Young has resi...
2025-08-21 04:49
美股大行评级 | 潜在涨幅921.1%！Intensity Therapeutics获Brookline Capital升级至"买入"，目标价上调至3美元
今日重点评级关注：Brookline Capital：上调Intensity Therapeutics评级至"买入"，目标价3美元；Chardan Capital：维持Taysha Gene Therapies"买入"评级，目标价从9美元升至10美元
2025-08-13 09:10
B. Riley Securities Maintains Buy on NPK International, Raises Price Target to $12.5
B. Riley Securities analyst Josh Nichols maintains NPK International (NYSE:NPKI) with a Buy and raises the price target from $11 to $12.5.
2025-08-07 23:18
12 Industrials Stocks Moving In Tuesday's After-Market Session
Gainers Orion Energy Sys (NASDAQ:OESX) shares rose 11.2% to $0.63 during Tuesd...
2025-08-06 05:07
NPK International enters $150M revolving credit facility
NPK International (NYSE:NPKI) has entered into a new credit agreement, which includes a $150M revolving loan facility, replacing the company’s previous asset-based revolving credit facility. The agree...
2025-06-23 19:11
Craig-Hallum Remains a Buy on NPK International (NPKI)
Craig-Hallum analyst Aaron Spychalla maintained a Buy rating on NPK Internation...
2025-03-12 20:38
美股大行评级 | CJS Securities：上调艾伦建材评级至"跑赢大市"，目标价110美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1102515815739830272.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Denali Therapeutics(DNLI)"买入"评级，目标价从80美元升至87美元</p> <p>• HC Wainwright & Co.：维持Car
2025-03-01 09:21
HC Wainwright & Co. Reiterates Buy on NPK International, Maintains $12 Price Target
HC Wainwright & Co. analyst Amit Dayal reiterates NPK International (NYSE:NPKI) with a Buy and maintains $12 price target.
2025-02-28 19:24
